• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Kyowa Kirin

FDA
Manufacturing

Lilly, Regeneron among 7 chosen for FDA PreCheck Pilot Program

Eli Lilly, Regeneron, Cellares and Fujifilm are among the seven companies that have been selected for the FDA's PreCheck Pilot Program.
Kevin Dunleavy Jun 30, 2026 9:57am
Asia

Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia

Mar 6, 2026 9:35am
Asia

OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia

Feb 6, 2026 9:48am
photo of a green light on a stoplight

Kyowa Kirin, Kura snag FDA nod for oral AML drug Komzifti

Nov 13, 2025 11:53am
newspaper

Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia

Oct 31, 2025 8:20am
Shanbally

BioMarin touts pipeline asset as potential Voxzogo replacement

Aug 5, 2025 11:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings